Patents by Inventor Robert E. Schoen

Robert E. Schoen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-mucin 1 binding agents and uses thereof
    Patent number: 10208125
    Abstract: This disclosure provides anti-MUC1 binding agents (e.g., antibodies and chimeric antigen receptors) and methods of treatment, prophylaxis, detection, and diagnosis using the same.
    Type: Grant
    Filed: July 14, 2014
    Date of Patent: February 19, 2019
    Assignees: University of Pittsburgh—Of the Commonwealth System of Higher Education, Bluefin BioMedicine, Inc.
    Inventors: Robert E. Schoen, Olivera J. Finn, Shuji Sato, Wan Cheung Cheung, Roberto D. Polakiewicz
  • ANTI-MUCIN 1 BINDING AGENTS AND USES THEREOF
    Publication number: 20160145343
    Abstract: This disclosure provides anti-MUC1 binding agents (e.g., antibodies and chimeric antigen receptors) and methods of treatment, prophylaxis, detection, and diagnosis using the same.
    Type: Application
    Filed: July 14, 2014
    Publication date: May 26, 2016
    Inventors: Robert E. Schoen, Olivera J. Finn, Shuji Sato, Wan Cheung Cheung, Roberto D. Polakiewicz
  • Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
    Patent number: 7838251
    Abstract: Proteins useful in the diagnosis of proliferative disorders of the colon are present in nuclear matrix protein preparations and can be characterized by molecular weight, isoelectric point, and amino acid sequence. The proteins may be identified, for example, by 2D-gel electrophoresis or by specific binding partners, such as antibodies.
    Type: Grant
    Filed: May 22, 2008
    Date of Patent: November 23, 2010
    Assignee: University of Pittsburgh
    Inventors: Gisela Bruenagel, Robert H. Getzenberg, Robert E. Schoen
  • NUCLEAR MATRIX PROTEIN ALTERATIONS ASSOCIATED WITH COLON CANCER AND COLON METASTASIS TO THE LIVER, AND USES THEREOF
    Publication number: 20090226935
    Abstract: Proteins useful in the diagnosis of proliferative disorders of the colon are present in nuclear matrix protein preparations and can be characterized by molecular weight, isoelectric point, and amino acid sequence. The proteins may be identified, for example, by 2D-gel electrophoresis or by specific binding partners, such as antibodies.
    Type: Application
    Filed: April 7, 2009
    Publication date: September 10, 2009
    Inventors: Anthony J. Bauer, Gisela Bruenagel, Robert H. Getzenberg, Robert E. Schoen
  • NUCLEAR MATRIX PROTEIN ALTERATIONS ASSOCIATED WITH COLON CANCER AND COLON METASTASIS TO THE LIVER, AND USES THEREOF
    Publication number: 20080248496
    Abstract: Proteins useful in the diagnosis of proliferative disorders of the colon are present in nuclear matrix protein preparations and can be characterized by molecular weight, isoelectric point, and amino acid sequence. The proteins may be identified, for example, by 2D-gel electrophoresis or by specific binding partners, such as antibodies.
    Type: Application
    Filed: May 22, 2008
    Publication date: October 9, 2008
    Inventors: Anthony J. Bauer, Gisela Bruenagel, Robert H. Getzenberg, Robert E. Schoen
  • Antibody against illfdyfnr
    Patent number: 7189823
    Abstract: Proteins useful in the diagnosis of proliferative disorders of the colon are present in nuclear matrix protein preparations and can be characterized by molecular weight, isoelectric point, and amino acid sequence. The proteins may be identified, for example, by 2D-gel electrophoresis or by specific binding partners, such as antibodies.
    Type: Grant
    Filed: May 20, 2005
    Date of Patent: March 13, 2007
    Assignee: University of Pittsburgh
    Inventors: Anthony J. Bauer, Gisela Bruenagel, Robert H. Getzenberg, Robert E. Schoen
  • Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
    Publication number: 20040018973
    Abstract: Proteins useful in the diagnosis of proliferative disorders of the colon are present in nuclear matrix protein preparations and can be characterized by molecular weight, isoelectric point, and amino acid sequence. The proteins may be identified, for example, by 2D-gel electrophoresis or by specific binding partners, such as antibodies.
    Type: Application
    Filed: January 24, 2003
    Publication date: January 29, 2004
    Applicant: University of Pittsburgh
    Inventors: Anthony J. Bauer, Gisela Bruenagel, Robert H. Getzenberg, Robert E. Schoen